SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant)

REQUEST MORE INFO
Catalogue No: abx620093
Price: US$290.00
(Size: 50 µg)

Click on the image to see the image legend

Available Options

* Size:



Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant) is a recombinant protein expressed in E. coli.

Target Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein (Omicron B.1.1.529 Variant)
Origin Virus
Expression Recombinant
Tested Applications SDS-PAGE
Host E. coli
Purity > 90% (SDS-PAGE)
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
NCBI Accession UFO69279.1
Molecular Weight Calculated MW: 46.31 kDa
Sequence Fragment Met1-Ala419
Tag N-terminal His tag
Buffer Prior to lyophilization: PBS, pH 7.5, 0.02 % NLS, 1mM EDTA, 4 % Trehalose, 1 % Mannitol
Standard Form A DNA sequence encoding the SARS-CoV-2 Nucleocapsid (YP_009724397.2, with mutations P13L, ERS31-33 deletion, R203K, G204R) (Met1-Ala419) was expressed with a polyhistidine tag at the N-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant B.1.1.529) which emerged in the South Africa.
Availability Shipped within 5-10 working days.
Note This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Research Articles on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein (Omicron B.1.1.529 Variant)


Write a review